Forum for Long-term Shareholders in Pharming Group

Transgenic Production Technology Platform: #Pharming's gepatenteerde technologieplatform; #Ruconest #rhC1INH #HAE; Ultra-rare disease #APDS: #Leniolisib

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming Group reports first quarter 2024 financial results and provides business update $PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming Group reports fourth quarter and full year 2023 financial results
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming Group reports third quarter 2023 financial results
$PHAR

[DeAandeelHouder.NL @deaandeelhouder]

Beursblik: Van Lanschot Kempen zet Pharming op de kooplijst https://t.co/RAbr6UnC75

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming Group to participate in September investor conferences
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming Group to convene Extraordinary General Meeting of Shareholders
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

CEO-Talk: Sijmen de Vries (Pharming) https://t.co/m5pI6yJQGn via @YouTube

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming Group reports second quarter and first half 2023 financial results
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming announces sale of priority review voucher
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming Group reports financial results for the first quarter of 2023
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Notice of First Quarter 2023 Results
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
$PHAR

[Forum for Long-term Shareholders in Pharming Group @PharmingForum]

#PharmingGroup $PHAR
Weekoverzicht KW13
Open: 1,374; close: 1,225 (-10,84%)
t.o.v. slot KW12: +23,05%;
High: 1,374; low: 1,109;
Volume: 154.674.800